Skeletal  	Skeletal  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
oral  	oral  	 JJ	I-NP
anticoagulants  	anticoagulants  	 JJ	I-NP
Vitamin  	Vitamin  	 NNP	I-NP
K  	K  	 NNP	I-NP
antagonists  	antagonists  	 NNS	I-NP
( 	( 	 -LRB-	O
VKA 	VKA 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
often  	often  	 RB	O
used  	used  	 VBN	O
as  	as  	 IN	O
oral  	oral  	 JJ	B-NP
anticoagulants  	anticoagulants  	 NNS	I-NP
( 	( 	 -LRB-	O
OA 	OA 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
thromboembolic  	thromboembolic  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
bone 	bone 	 NN	O
,  	,  	 ,	O
vitamin  	vitamin  	 VBG	B-NP
K  	K  	 NNP	I-NP
reduces  	reduces  	 VBZ	O
bone  	bone  	 JJ	B-NP
resorption  	resorption  	 NN	I-NP
and  	and  	 CC	O
functions  	functions  	 NNS	O
as  	as  	 IN	O
a  	a  	 DT	O
co-factor  	co-factor  	 JJ	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
post-translational  	post-translational  	 JJ	B-NP
carboxylation  	carboxylation  	 NN	I-NP
of  	of  	 IN	O
several  	several  	 JJ	O
bone  	bone  	 NN	O
proteins 	proteins 	 NNS	O
.  	.  	 .	O
Osteocalcin  	Osteocalcin  	 NNP	B-NP
( 	( 	 -LRB-	O
OC 	OC 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
most  	most  	 RBS	O
abundant  	abundant  	 JJ	O
of  	of  	 IN	O
these  	these  	 DT	O
bone  	bone  	 NN	O
matrix  	matrix  	 NN	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
is  	is  	 VBZ	O
produced  	produced  	 VBN	O
by  	by  	 IN	O
osteoblasts  	osteoblasts  	 NN	B-NP
and  	and  	 CC	O
released  	released  	 VBN	O
in  	in  	 IN	O
small  	small  	 JJ	O
amounts  	amounts  	 NNS	O
in  	in  	 IN	O
blood  	blood  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
specific  	specific  	 JJ	O
marker  	marker  	 NN	O
of  	of  	 IN	O
bone  	bone  	 NN	O
formation 	formation 	 NN	O
.  	.  	 .	O
Carboxylated  	Carboxylated  	 JJ	B-NP
proteins  	proteins  	 NNS	I-NP
have  	have  	 VBP	O
a  	a  	 DT	O
high  	high  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
calcium  	calcium  	 NN	I-NP
and  	and  	 CC	O
are  	are  	 VBP	O
important  	important  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
incorporation  	incorporation  	 NN	B-NP
of  	of  	 IN	I-NP
calcium  	calcium  	 NN	I-NP
into  	into  	 IN	O
bone  	bone  	 NN	O
and  	and  	 CC	O
bone  	bone  	 NN	O
formation 	formation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
increased  	increased  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
undercarboxylated  	undercarboxylated  	 JJ	B-NP
osteocalcin  	osteocalcin  	 NN	I-NP
can  	can  	 MD	O
bring  	bring  	 VB	O
about  	about  	 IN	O
an  	an  	 DT	O
alteration  	alteration  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
bone  	bone  	 NN	O
mineral  	mineral  	 NN	O
density  	density  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
fracture 	fracture 	 NN	B-NP
,  	,  	 ,	O
even  	even  	 RB	O
if  	if  	 IN	O
contradictory  	contradictory  	 JJ	B-NP
results  	results  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
several  	several  	 JJ	O
epidemiologic  	epidemiologic  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
some 	some 	 DT	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
all  	all  	 DT	O
reports 	reports 	 NNS	O
,  	,  	 ,	O
find  	find  	 VB	O
that  	that  	 DT	O
vitamin  	vitamin  	 JJ	B-NP
K  	K  	 NNP	I-NP
deficiency 	deficiency 	 NN	I-NP
,  	,  	 ,	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
hydroxycoumarins 	hydroxycoumarins 	 NN	B-NP
,  	,  	 ,	O
may  	may  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
low  	low  	 JJ	O
bone  	bone  	 NN	O
mass 	mass 	 NN	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
epidemiologic  	epidemiologic  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
found  	found  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
OA  	OA  	 NNP	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
either  	either  	 DT	O
increased  	increased  	 JJ	O
or  	or  	 CC	O
no  	no  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
fracture  	fracture  	 JJ	B-NP
risk 	risk 	 NN	I-NP
.  	.  	 .	O
Such  	Such  	 JJ	O
divergent  	divergent  	 JJ	O
results  	results  	 NNS	O
may  	may  	 MD	O
imply  	imply  	 VB	O
that  	that  	 DT	O
human  	human  	 JJ	O
studies  	studies  	 NNS	O
are  	are  	 VBP	O
compromised  	compromised  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
physical  	physical  	 JJ	B-NP
illnesses  	illnesses  	 NNS	I-NP
for  	for  	 IN	O
which  	which  	 WDT	O
OA  	OA  	 NNP	B-NP
were  	were  	 VBD	O
prescribed 	prescribed 	 VBN	O
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
epidemiological  	epidemiological  	 NN	I-NP
or  	or  	 CC	O
cohort  	cohort  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
warranted  	warranted  	 VBN	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
potential  	potential  	 JJ	B-NP
pharmacological  	pharmacological  	 JJ	I-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
VKA  	VKA  	 NNP	I-NP
on  	on  	 IN	O
bone  	bone  	 NN	O
metabolism  	metabolism  	 NN	O
may  	may  	 MD	O
have  	have  	 VB	O
clinical  	clinical  	 JJ	B-NP
consequences 	consequences 	 NNS	I-NP
.  	.  	 .	O
